Tom Venken

5PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 18, 2025
Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trial.

Halit Topal, Tom Venken, Ayse Bassez

|Oct 16, 2024
Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis.

Sanket More, Julie Bonnereau, David Wouters

|Apr 12, 2023
Multiomics and spatial mapping characterizes human CD8<sup>+</sup> T cell states in cancer.

Stefan Naulaerts, Angeliki Datsi, Daniel M Borras

|Mar 18, 2023
Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer.

Elien Heylen, Paulien Verstraete, Linde Van Aerschot

|Apr 28, 2022
Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer.

Adriaan Vanderstichele, Pieter Busschaert, Chiara Landolfo

Pageof 1

Frequent Collaborators

5 joint publications

Diether Lambrechts

2 joint publications

Francesca Bosisio

2 joint publications

Oliver Bechter

2 joint publications

Stefan Naulaerts